Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Pharma & Drugs
Share your love
Endogena Receives FDA Fast Tract Designation for RP
Endogena Therapeutics announced that the US FDA has designated the investigation of its drug EA-2353 for the treatment of retinitis pigmentosa (RP) as a Fast Track development program. This process speeds up the availability of new drugs for serious conditions…
Nidek Introduces Cube Alpha Ophthalmic Surgical System
Nidek has introduced the Cube α ophthalmic surgical system, which is designed to incorporate new ultrasound technology for enhanced phacoemulsification. Nidek reports that the Cube α features Gyro torsional technology within its compact design. The torsional ultrasound oscillation enhances the…
Smart Contact Lens That Diagnoses and Treats Glaucoma
A research team at POSTECH has recently developed a wireless theranostic smart contact lens that combines an IOP sensor and a flexible drug delivery system to control IOP measurement and drug administration in glaucoma. Glaucoma is a common eye disease…
FDA Approves Bausch + Lomb’s Photodynamic Laser
Bausch + Lomb and Modulight Corporation, a biomedical laser company, today announced that the FDA has approved the ML6710i photodynamic laser for equivalent use with Bausch + Lomb’s VISUDYNE® (verteporfin for injection) photodynamic therapy (PDT) for the treatment of patients…
Intraocular Lens Market to Reach $6.7 Billion
The global intraocular lens market is projected to grow from its current valuation of $4.1 billion to $6.7 billion by the end of 2032, according to a recent report by Fact Market Research (FMR). The market is expected to expand…
Regeneron Wins Patens Case Against Novartis
Regeneron Pharmaceuticals Inc. has won a patent case against Novartis AG in a U.S. court, protecting the company’s drug delivery system for its eye drug Eylea. The US Patent Trial and Appeal Board ruled in favor of Regeneron, stating that…
High-Tech Contact Lenses May Replace Smart Phones
When Alexander Graham Bell brought us the revolutionary first ever telephone back in 1876, the world was changed forever. Ever since then, telephonic devices have been a mainstay of the modern world; an essential part of our everyday lives. Of…
Viatris Closes Oyster Point, Famy Life Acquisitions
Viatris announced the completion of its acquisitions of Oyster Point Pharma and Famy Life Sciences to establish a new Viatris Eye Care Division. On November 7, the purchase was originally announced. Jeffrey Nau, PhD, MMS, former CEO of Oyster Point…
Sifi and Avanzanite Sign License Agreement
Italy-based Sifi formed a collaboration with Avanzanite Bioscience, a Dutch specialty pharmaceutical business, to commercialize and distribute Akantior (polihexanide) exclusively in 26 European Economic Area and Swiss countries. Sifi will manage all ongoing regulatory activities under the terms of the…
Harrow Now Offering Fortisite Formulations for In-Office Use
Harrow announced the availability of Fortisite (compounded Tobramycin 1.5% + Vancomycin 5%) for in-office use from its FDA-registered and FDA-inspected ImprimisRx 503B outsourcing facility. Fortisite formulations are high-concentration, refrigeration-stable, fortified antibiotic formulations in solution that are patent-pending. According to Harrow,…